This study aimed to evaluate what is new in the controversial use of testosterone, as an indication pathologies such hypogonadism or its by athletes and bodybuilders search performance. Much said about subject many myths were created without any scientific foundation, one objectives monograph show that when there a precise clinical indication, testosterone necessary extremely beneficial patient...

INTRODUCTION REPRODUCTIVE PHYSIOLOGY ANTERIOR PITUITARY TESTES FEEDBACK CONTROL OF GONADOTROPINS PROLACTIN AND GONADOTROPINS ANDROGEN PHYSIOLOGY HORMONAL CONTROL OF SPERMATOGENESIS DIAGNOSING ENDOCRINE ABNORMALITIES: CLINICAL FINDINGS SEMEN ANALYSIS BASELINE HORMONE EVALUATION DYNAMIC HORMONAL TESTING CLASSIFICATION OF ENDOCRINE CAUSES OF INFERTILITY PRIMARY HYPOGONADISM SECONDARY HYPOGONADISM ...

Evidence suggests that providers are not adhering to current testosterone replacement therapy guidelines when treating male hypogonadism. Understanding the diagnosis and management of this condition is further complicated by conflicting recommendations among available guidelines. NPs must select and follow the best guideline recommendations available to optimally treat male hypogonadism.

INTRODUCTION REPRODUCTIVE PHYSIOLOGY ANTERIOR PITUITARY TESTES FEEDBACK CONTROL OF GONADOTROPINS PROLACTIN AND GONADOTROPINS ANDROGEN PHYSIOLOGY HORMONAL CONTROL OF SPERMATOGENESIS DIAGNOSING ENDOCRINE ABNORMALITIES: CLINICAL FINDINGS SEMEN ANALYSIS BASELINE HORMONE EVALUATION DYNAMIC HORMONAL TESTING CLASSIFICATION OF ENDOCRINE CAUSES OF INFERTILITY PRIMARY HYPOGONADISM SECONDARY HYPOGONADISM ...

1. To recognize hypergonadotropic hypogonadism as part of the differential diagnosis of delayed puberty 2. To recognize premature ovarian failure as a cause of hypergonadrotropic hypogonadism 3. To recognize chemotherapy and cancer treatment modalities as etiologies of gonadal failure 4. To understand that it is hard to predict which patients will resume normal ovarian function after chemothera...

Chronic pulsatile subcutaneous administration of low doses of gonadotrophin releasing hormone (GnRH) is an effective therapy for men with hypogonadotrophic hypogonadism. Hypersensitivity reactions to GnRH are rare. We wish to report hypersensitivity reactions with intravenous GnRH after low dose subcutaneous pulsatile GnRH treatment in two men with hypogonadotrophic hypogonadism due to suprasel...

Hypogonadism is a potential complication of haemochromatosis, usually seen in patients with severe iron overload and liver cirrhosis. We describe the diagnostic workup of a patient with an early stage of hereditary haemochromatosis, presenting with only mildly elevated liver enzymes and central hypogonadism in the absence of cirrhosis or diabetes, but with concurrent sarcoidosis.

There is an increased risk of development of carcinoma of the breast in males with hypogonadism due to Klinefelter's syndrome. A patient with isolated hypogonadotropic hypogonadism and gynaecomastia developed an intraduct carcinoma of the breast. This is believed to be the first reported case of this association.

INTRODUCTION REPRODUCTIVE PHYSIOLOGY ANTERIOR PITUITARY TESTES FEEDBACK CONTROL OF GONADOTROPINS PROLACTIN AND GONADOTROPINS ANDROGEN PHYSIOLOGY HORMONAL CONTROL OF SPERMATOGENESIS DIAGNOSING ENDOCRINE ABNORMALITIES: CLINICAL FINDINGS SEMEN ANALYSIS BASELINE HORMONE EVALUATION DYNAMIC HORMONAL TESTING CLASSIFICATION OF ENDOCRINE CAUSES OF INFERTILITY PRIMARY HYPOGONADISM SECONDARY HYPOGONADISM ...